Correspondence 0001193125-23-149454 from BIOCEPT INC (BIOCQ) (CIK 0001044378)
BIOCEPT INC (BIOCQ) (CIK 0001044378)
Date: May 19, 2023 · CIK: 0001044378 · Accession: 0001193125-23-149454
AI Filing Summary & Sentiment
File numbers found in text: 333-271355
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 19, 2023 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Biocept, Inc. Registration Statement on Form S-1 (File No. 333-271355) Ladies and Gentlemen: In connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), EF Hutton, Division of Benchmark Investments, LLC, as representative of the underwriters, hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 9:00 a.m. (New York time) on May 22, 2023, or as soon thereafter practicable. In making this request, the undersigned acknowledges that the underwriters are aware of their obligations under the Act as they relate to the public offering of securities pursuant to the registration statement. [signature page follows] Very truly yours, EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS, LLC By: /s/ Sam Fleischman Name: Sam Fleischman Title: Supervisory Principal